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Abstract
Background: Bacterial and cellular genotyping is becoming increasingly important in the diagnosis
of infectious diseases. However, difficulties in obtaining sufficient amount of bacterial and cellular
DNA extracted from the same human biopsy specimens is often a limiting factor. In this study, total
DNA (host and bacterial DNA) was isolated from minute amounts of gastric biopsy specimens and
amplified by means of whole genome amplification using the multiple displacement amplification
(MDA) technique. Subsequently, MDA-DNA was used for concurrent Helicobacter pylori and human
host cellular DNA genotyping analysis using PCR-based methods.
Results: Total DNA was isolated from gastric biopsy specimens of 12 subjects with gastritis and
16 control subjects having a normal mucosa. The DNA was amplified using a multiple displacement
amplification (MDA) kit. Next, concurrent genotyping was performed using H. pylori-specific
virulence gene PCR amplification assays, pyrosequencing of bacterial 16S rDNA and PCR
characterisation of various host genes. This includes Interleukin 1-beta (IL1B) and Interferon-
gamma receptor (IFNGR1) SNP analysis, and Interleukin-1 receptor antagonist (IL1RN) variable
tandem repeats (VNTR) in intron 2. Finally, regions of the vacA-gene were PCR amplified using
M13-sequence tagged primers which allowed for direct DNA sequencing, omitting cloning of PCR
amplicons. H. pylori specific multiplex PCR assays revealed the presence of H. pylori cagA and vacA
genotypic variations in 11 of 12 gastritis biopsy specimens. Using pyrosequencing, 16S rDNA
variable V3 region signatures of H. pylori were found in 11 of 12 individuals with gastritis, but in
none of the control subjects. Similarly, IL1B and IFNGR1-SNP and IL1RN-VNTR patterns could be
established in all individuals. Furthermore, sequencing of M13-sequence tagged vacA-PCR amplicons
revealed the presence of highly diverse H. pylori vacA-s/i/m regions.
Conclusion:  The PCR-based molecular typing methods applied, using MDA-amplified DNA
derived from small amounts of gastric biopsy specimens, enabled a rapid and concurrent molecular
analysis of bacterial and host genes in the same biopsy specimen. The principles and technologies
used in this study could also be applied to any situation in which human host and microbial genes
of interest in microbial-host interactions would need to be sequenced.
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Background
The Gram-negative spiral shaped bacterium Helicobacter
pylori [1] is associated with the development of a variety of
gastroduodenal diseases such as chronic gastritis, peptic
ulcer disease and gastric cancer [2,3]. Virulence factors
have been identified, including the production of urease
(ureA) [4], a vacuolating cytotoxin (vacA) [5,6], and a
cytotoxin-associated antigen (cagA) [7,8]. It has been
implied that ureA [9], superoxide dismutase (sod) [10] and
heat-shock protein 60 (hsp60) [11], found exclusively
within the cytoplasm in other bacteria, are associated with
the outer membrane in H. pylori. It is assumed that the var-
iation in disease progression between patients is likely
due to differences in bacterial virulence genes.
The H. pylori cytotoxin gene vacA is an important virulence
marker. DNA sequence analysis has revealed that the vacA
has a mosaic structure comprising allelic variations in the
signal and midregion, each having two different alleles
(s1/s2, m1/m2) with different biological activities [5,12].
Furthermore, it has been shown that the repeated
hydrophilic motif region (RHM) is a potential proteolytic
cleavage-site that separates the VacA-94 kDa protein into
a 58-kDa and a 37-kDa protein with different biological
activities [6,13]. Amino-acid substitutions, insertions and
deletions within the RHM-region have been reported
[14,15]. It has been speculated that mutations such as
truncations, insertions and deletions in the midregion of
the vacA gene which lead to in-frame stop codons, are
associated with non-toxic H. pylori strains [14]. Recently,
it has been shown that the vacA intermediate region (vacA
i-region) may provide an important and independent
marker of VacA-associated pathogenicity [16].
It is well recognised that the development of gastric dis-
ease is strongly influenced by host genetic factors.
Cytokines play an important role in H. pylori-induced dis-
ease. An association of increased risk of gastric cancer and
IL1B polymorphisms [17-19] and IL1RN polymorphisms
[17,19-21] has been established. The IFNGR1 allele *2
has been associated with high H. pylori-reactive immu-
noglobulin G antibody concentrations [22] and an
increased risk for atrophic gastritis [23]. Thus, for charac-
terisation of bacterium-host interactions, it would appear
that a concurrent typing of Helicobacter-specific virulence
genes and cytokine polymorphisms in the same DNA, iso-
lated only once from a biopsy specimen, is desirable.
Numerous PCR assays have been developed for the iden-
tification of H. pylori-specific virulence genes, reviewed in
[15]. To reduce the number of H. pylori-specific virulence
gene-based PCR amplification assays needed for such
characterisation, we and others have developed multiplex
PCR amplification assays which allow a highly sensitive
detection and accurate genotyping of H. pylori-DNA
[15,24-26]. A recent study described a method along these
lines which allowed for concurrent genotyping analysis of
H. pylori 16S rDNA, 23S rDNA, cagA genes, and the cellu-
lar IL1B gene [27].
However, due to the low amount of bacterial DNA present
in human biopsy specimens, the molecular identification
of bacteria is often regarded impossible without culturing.
To increase the specificity and sensitivity of the analysis of
H. pylori infected biopsy specimens, nested PCR amplifi-
cation in itself [28] or combined with Southern blot anal-
ysis of PCR amplicons has been used for molecular typing
[29,30]. Identification of PCR amplicons by DNA
sequence analysis employing time-consuming and expen-
sive cloning, and subsequent plasmid DNA isolation pro-
cedures has also been used. However, these methods are
not well suited for large-scale epidemiological screening
and in this context, alternative techniques such as direct
sequencing of M13-sequence tagged PCR amplicons for
molecular typing of i. e. Staphylococcus aureus protein A
(SPA-typing) [31], and whole genome amplification
(WGA) of DNA using multiple displacement amplifica-
tion (MDA) have been developed [32,33].
MDA is a PCR independent isothermal amplification
technique that relies on the amplification of total
genomic DNA, using a chemically modified random hex-
amer primer at 30°C and a bacteriophage Phi29 proof-
reading DNA polymerase, completing amplification
within a few hours [32,34]. This technique dramatically
improves the high-fidelity production of large amounts of
genomic DNA with uniform coverage of genes [35-37].
We have recently reported on the use of MDA for amplifi-
cation of DNA isolated from human intestinal biopsies
[38], human gallstones specimens [39], and archival
plasma/serum samples [40] for subsequent use in molec-
ular typing of H. pylori and host genes.
In this study, we report on the use of MDA-amplified DNA
for the molecular analysis of bacterial and human host
genes in minute amounts of gastric biopsy specimens.
Moreover, we report on the successful PCR amplicon
sequencing, using a single, universal M13 uni (-21)
primer targeting all M13-sequence tagged PCR amplicons.
Methods
Study subjects, tissue collection and DNA isolation
Fresh frozen (-80°C) archival tissue samples from 28 sub-
jects from a previous study which was approved by the
local ethics committee and conducted in accordance with
the Helsinki Declaration, including informed written con-
sent, were used [41]. Based on histological findings and
rapid urease test from a larger (n = 501) gastroscopic
screening study in a randomly selected cohort of the pop-
ulation of Linköping, Sweden [41], a total of 28 individu-BMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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als (14 men; median age 58, range 42–73 and 14 women;
median age 65, range 43–76) were selected and included
in the present study. Among the 12 individuals with gas-
tritis, four had antrum gastritis, five had pangastritis and
two subjects had corpus gastritis with H. pylori infection,
respectively, and one individual had corpus gastritis with-
out an obvious H. pylori infection. All sixteen control sub-
jects were H. pylori-negative and had a normal gastric
mucosa (for details see table 1). DNA from gastric biopsy
specimens and bacterial strains Helicobacter pylori 26695
and J99, respectively, were extracted using a BioRobot M-
48 Workstation and a MagAttract DNA Mini-48 kit as rec-
ommended by the manufacturer (Qiagen, Hilden, Ger-
many).
Generation of MDA-amplified DNA
MDA of the isolated DNA was carried out using a Genom-
iPhi DNA amplification kit as recommended by the man-
ufacturer (GE-Healthcare, Uppsala, Sweden). DNA
concentrations were determined using a ND-1000 spec-
trophotometer (Nanodrop Technologies, Wilmington,
DE, USA). Three separate MDA reactions were performed
from each sample. The integrity of the MDA-amplified
DNA was analysed by Ethidium bromide stained agarose-
gel electrophoresis. Appropriate amounts (usually 1 to 2
μl) were used in subsequent PCR amplification assays.
18S rRNA and 16S rRNA PCR amplification
To evaluate the integrity of the prepared MDA-amplified
DNA derived from total biopsy DNA, subsequent 18S
rDNA and 16S rDNA PCR amplification was performed.
In brief, 18S rDNA PCR amplification was carried out
using a Quantum 18S rDNA internal standard kit as rec-
ommended by the manufacturer (Ambion, Austin, TX,
USA) yielding a 489 bp PCR amplicon. 16S rDNA PCR
amplification yielding an approximately 450 bp amplicon
was carried out using 16S rDNA broad-range primers [42]
flanking the variable V3, V4 and V9 regions (Table 2) and
PCR amplification condition No 3 (Table 3) in a final 25
μl reaction volume using thin walled tubes, a HotStarTaq
Master-mix kit (Qiagen, Hilden, Germany), and a PTC-
100 Thermocycler (MJ-Research; SDS-Biosciences, Falken-
berg, Sweden) or Mastercycler gradient (Eppendorf, Ham-
burg, Germany) as previously described [38].
Pyrosequencing analysis
Pyrosequencing template generation was performed using
16S rDNA broad-range PCR amplicons as a template (see
above). For that purpose, broad-range 16S rDNA PCR
amplicons were purified using a GFX PCR DNA and Gel-
band purification kit (GE Healthcare, Uppsala, Sweden)
and pyrosequencing PCR amplicons were generated using
an appropriate amount (usually 1 μl) of 16S rDNA tem-
plate, a HotStarTaq Master mix kit (Qiagen AB, Solna,
Sweden), 5 pmol each of Helicobacter-specific primer 5'-
biotin HJ-HP-JBS.V3 and broad-range primer B-V3.AS
(Table 2), both flanking the 16S rDNA V3 region only,
and PCR condition No 1 (Table 3). Pyrosequencing anal-
ysis was carried out as described elsewhere [43] using a
PSQ 96 MA System (Biotage AB, Uppsala, Sweden) and
sequencing primer B-V3.AS (Table 2).
H. pylori-specific virulence-gene multiplex PCR 
amplification
vacA, hsp60, ureI, sod, ureA and cagA (Table 2) multiplex
PCR amplification was carried out using 5 pmol of each
primer and PCR amplification condition No1 (Table 3)
[15]. For vacA subtyping, a duplex PCR using primers VAI-
F and VAI-R specific for vacA s1/s2 genotypes, primers
VAG-F and VAG-R (Fig. 1; Table 2) specific for vacA m1/
Table 1: Sample information and H. pylori 16S rDNA V3 
sequence motif.
Number Gastritis classificationa H. pylori 16S rDNAb
1N -
2N -
3N -
4N -
5N -
6 P-2-na "strain A"c
7N -
8 C-1-na -
9 A-1-a J99
10 N -
11 N -
12 C-3-a 26695
13 N -
14 A-1-a 26695
15 N -
16 N -
17 N -
18 P-1-na 26695
19 N -
20 N -
21 P-1-na J99
22 C-1-a J99
23 P-2-na 26695
24 N -
25 P-2-na 26695
26 N -
27 A-1-a 26695
28 A-1-na 26695/J99d
Antral biopsy specimens, type of gastritis and H. pylori 16S rDNA 
variable V3 region sequence motif derived from whole genomic 
amplified gastric biopsy DNA.
a) Gastritis classification according to Sydney system [57].
N: normal gastric mucosa; A: antrum predominant gastritis; P: 
pangastritis; C: corpus predominant gastritis. 1: mild degree; 2: 
moderate degree; 3: severe degree. a: atrophy; na: no atrophy.
b) Based on pyrosequencing analysis.
c) The 16S rDNA variable V 3 region sequence motif corresponds to 
H. pylori "strain A", [GenBank:DQ059082] (Fig. 2, group III).
d) The 16S rDNA variable V 3 region sequence motif corresponds to 
a H. pylori 26695/J99-like combination of H. pylori 26695 and J99 (Fig. 
2, group IV).BMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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Table 2: Oligonucleotides used in the present study.
Primer Primer sequence 5'-3' direction PCR product (bp) Gene/Region Ref.d
pJB-1.SE attcgatgcaacgcgaagaaccttacc ~430 16S rDNA
p13B.AS gtgtactaggcccgggaacgtattc (V3, V4, V9) [38]
bio-HJ-HP-JBS.V3.SE bio-cctaggcttgacattgaiagaa ~90 HP-16S rDNA
B-V3.AS acgacagccatgcagcacct pyrosequencing
vacA-1.SE caatcgtgtgggttctggagc 678 vacA
vacA-3.AS gccgatatgcaaatgagccgc [15]
hsp60-1.SE gctccaagcatcaccaaagacg 603 hsp60
hsp60-3.AS gcggtttgccctctttcatgg
ureI-3.SE cagcaatgggatttgcgggttaacca 511 ureI
ureI-4.AS gatccaagcggttaaaataccctcaatgga
sod-1.SE gccctgtggcgtttgatttcc 425 sodB
sod-3.AS catgctcccacacatccacc
ureA-1.SE gcggctgaattgatgcaagaagg 350 ureA
ureA-3M.SE gctcgcaatgtctaagcgtttaccgaa
cagA-2.SE gaaatttggggatcagcgttacc 180 cagA
cagA-3.AS tcctgcaaaagattgtttggcaga
VAI-F atggaaatacaacaaacacac 259/286 vacA s1/s2
VAI-R ctgcttgaatgcgccaaac [26]
VAG-F caatctgtccaatcaagcgag 567/642 vacA m1/m2
VAG-R gcgtcaaaataattccaagg
M13a-SeqS.SE cgttgtaaaacgacggccagtga-ccctttgtgcaaaaatcgtt 381 vacA gene,
SeqS.AS cccarcctccatcaatctt signal region
M13a-SeqVac.SE cgttgtaaaacgacggccagtga-gccaattcaayggcaattct 803 vacA RHM pr.
SeqVac.AS cgcttgattggacagattga and i-region
M13a-SeqM.SE cgttgtaaaacgacggccagtga-agtcrttgatgggccttttg 717b vacA gene, midregion
IL1B-511F1.SE tatgttctctgccccagcca 133 IL1B-511
bio-IL1B-511R1.AS bio-aatagccctccctgtctgtattga rs16944c pr.
Seq-IL1B-511.S1 gcaattgacagagagct pyrosequencing
bio-IL1B-31F1.SE bio-atttctcagcctcctacttctgc 76 IL1B-31
IL1B-31R1.AS aagaggtttggtatctgccagttt rs1143627c pr.
Seq-IL1B-31.S1 ccctcgctgtttttat pyrosequencing
hIL1B+3954.AS cggagcgtgcagttcagtgat 152 IL1B +3954
bio-IL1B+3954.SE bio-aattttgccgcctcgcctca rs1143634c [27]
IL1B+3954 cgttatcccatgtgtc pyrosequencing
IFNGR1.SE ggtgacggaagtgacgtaagg 106 IFNGR1-56
bio-IFNGR1.AS gaggagagccatgctgctac rs2234711c pr.
Seq-IFNGR1.S2 gccggggctggaggg pyrosequencing
IL1RNF1.SE cccctcagcaacactcc 270/356/442 IL1RN 86bp [17]
IL1RNR1.AS ggtcagaagggcagaga /528/614 VNTR/Intron 2
a) underlined sequence corresponds to a M13-sequence adapter used in DNA sequencing.
b) expected PCR product using M13-SeqM.SE and VAG-R primers.
c) rs: Reference SNP identification number [58]
d) pr. – present study.BMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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m2 genotypes [24,26], and PCR condition No 1 were used
(Table 3). PCR amplicons were analysed on the auto-
mated capillary electrophoresis QIAxcel system and a
QIAxcel DNA high resolution kit (Qiagen, Hilden, Ger-
many).
Cytokine polymorphism analysis
MDA-amplified DNA was analysed by pyrosequencing for
the presence of IL1B- and IFNGR1-polymorphisms. Prim-
ers flanking the IL1B-511 [ref SNP ID:rs16944],IL1B-31
[rs1143627]and  IFNGR1-56 [rs2234711] regions were
designed based on the available genomic IL1B  [Gen-
Bank:AY137079] and IFNGR1  sequences [Gen-
Bank:AY594694] using a PSQ Assay Design software
(Biotage AB, Uppsala, Sweden). Templates for pyrose-
quencing SNP analysis were obtained by PCR amplifica-
tion using 1 μl of MDA-amplified DNA, 5 pmol of each
primer flanking the IL1B-511,  IL1B-31,  IL1B+3954
[rs1143634] and the IFNGR1-56 regions (Table 2), and
PCR amplification condition No 2 for IL1B-511, IL1B-31
and IFNGR1 primers and No 3 for IL1B +3954 primers
(Table 3). Pyrosequencing analysis was performed as
described elsewhere [40,43] with the modification of
using a PSQ 96MA System, and the pyrosequencing prim-
ers specified in table 2.
The 86 bp variable number tandem repeat (VNTR) in
intron 2 of the IL1RN gene was amplified using the prim-
ers IL1RNF1.SE and IL1RNR1.AS (Table 2) and PCR
amplification No 5 (Table 3) followed by automatic cap-
illary electrophoresis analysis using a QIAxcel system and
a QIAxcel DNA high resolution kit (Qiagen, Hilden, Ger-
many). So far, five VNTR alleles have been reported; allele
*1–*5 having four, two, five, three, and six repeats, corre-
sponding to amplicon sizes of 442 bp, 270 bp, 528 bp,
356 bp and 614 bp, respectively.
Table 3: PCR amplification conditions used in the present study.
PCR No Initial denaturation Denaturation Annealing Extension No of cycles Final extension
1 95°C; 15 min 95°C; 30 s 56°C; 30 s 72°C; 1 min 30 72°C; 10 min
2 95°C; 15 min 95°C; 30 s 62°C; 30 s 72°C; 1 min 30 72°C; 10 min
3 95°C; 15 min 95°C; 30 s 55°C; 30 s 72°C; 1 min 30 72°C; 10 min
4 95°C; 15 min 95°C; 30 s 57°C; 30 s 72°C; 1 min 37 72°C; 10 min
5 95°C; 15 min 95°C; 30 s 65°C, 30 s 72°C; 30 s 5 72°C; 10 min
95°C; 30 s 60°C; 30 s 72°C; 30 s 25
95°C; 30 s 55°C; 30 s 72°C; 30 s 5
VacA-primers Figure 1
VacA-primers. Schematic representation of the approximate location of the vacA-primers used in the present study (Table 2). 
SS = signal sequence region; ATR = amino-terminal region; MR = middle-region; CTR = Carboxyterminal region (nomencla-
ture adapted from [50]).
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DNA sequence analysis of vacA PCR amplicons
Sequence data from Helicobacter pylori J99 [Gen-
Bank:AE001439], H. pylori 26695 [GenBank:AE000511],
H. pylori NCTC 11638 [GenBank:U07145], and H. pylori
unspecified [GenBank:U29401] for vacA  primer design
were retrieved from GenBank [44] and aligned using Clus-
talX [45]. Primers were designed and checked using
Primer3 [46] and optimized by annealing temperature
gradient PCR and Mg2+ concentration.
To identify and establish vacA s/i/m genotype, 2 μl MDA-
amplified DNA derived from the 11 H. pylori-positive
biopsies were PCR amplified with three new vacA-specific
primer pairs, using 10 pmol of each primer and PCR con-
dition No 4 (Table 3). The s-region was amplified with
primer M13-SeqS.SE and SeqS.AS, the RHM and i-region
with primers M13-seqVac.SE and seqVac.AS, and the m-
region with primers M13-seqM.SE and VAG-R (Fig. 1;
Table 2) yielding M13-sequence (M13 uni, -21) tagged
PCR amplicons. PCR amplicons were treated with
ExoSAP-IT to inactivate excess of oligonucleotide primers,
following the manufacturer's instructions (USB Europe
GmbH, Staufen, Germany), and lyophilised. Subsequent
DNA sequence analysis was carried out using a custom
DNA sequencing service (Eurofins MWG GmbH, Martin-
sried, Germany). H. pylori MDA-amplified DNA No 18
was further amplified using the primer combination M13-
SeqVac.SE and VAG-R at the conditions described above.
The obtained sequences corresponding to the 11 H. pylori-
DNA vacA s-regions were aligned and compared with cat-
alogued H. pylori vacA type s1a [GenBank:AY185128], s1b
[GenBank:AB057223], s2 [GenBank:AY438687], and s1c
[GenBank:AB057107] sequences using CLC DNA work-
bench 3 (CLC bio A/S, Aarhus, Denmark). Similarly, DNA
sequences corresponding to the vacA  i/m-regions were
aligned and compared with catalogued H. pylori vacA type
i1/m1 [GenBank:U05676] and type i2/m2 [Gen-
Bank:U29401] sequences.
Results
MDA-amplified DNA
Each biopsy yielded approximately 2–4 μg total DNA
(A260/280 > 1.8) in a final volume of 150 μl water. On aver-
age, 1 μl genomic DNA generated approximately 12–22
μg MDA-amplified DNA. 18S rDNA and 16S rDNA PCR
amplification using MDA-amplified DNA yielded PCR
amplicons of the expected sizes, 490 bp and 450 bp,
respectively (data not shown).
Presence of Helicobacter spp.-DNA in antrum biopsies
MDA-amplified DNA derived from 28 antrum biopsies
was analysed for the presence of Helicobacter spp.-DNA.
Pyrosequencing analysis revealed that 11 of 28 subjects
were infected with H. pylori. H. pylori 16S rDNA sequences
were detected only in biopsy specimens from patients
with diagnosed gastritis (Table 1). 16S rDNA variable V3
region sequence motifs corresponding to H. pylori 26695
and J99 were detected in six and three samples, respec-
tively. Two specimens had deviating V3 region sequence
motifs (Fig. 2); H. pylori sequence No 6 corresponds to the
V3 sequence motifs of H. pylori "strain A" [Gen-
Bank:DQ059082] and H. pylori sequence No 28 corre-
sponds to a H. pylori 26695/J99-like combination of
26695 and J99. In the remaining 17 biopsies, Helicobacter
spp.-DNA was not detected (Table 1).
Multiplex PCR amplification
H. pylori-positive MDA-amplified DNA (based on 16S
rDNA pyrosequencing analysis), and H. pylori 26695 and
J99-DNA as references (Table 1) were further analysed by
the H. pylori virulence gene-based multiplex PCR amplifi-
cation assay. Capillary electrophoresis revealed hsp60,
H. pylori 16S V3 pyrosequencing results Figure 2
H. pylori 16S V3 pyrosequencing results. DNA sequence alignment of the 16S rDNA variable V3 region of Helicobacter 
isolates derived from pyrosequencing analysis. Dashes indicate sequence identity with H. pylori 26695. Roman numerals indicate 
four Helicobacter-specific 16S rDNA variable V3 region sequence motif-groups [43]. The number of Helicobacter isolates in each 
group is indicated in parentheses. Group I, H. pylori strain 26695-like [GenBank:AE000620]: No 12, 14, 18, 23, 25, 27. Group II, 
H. pylori strain J99-like [GenBank:NC_000921]: No 9, 21, 22. Group III H. pylori strain A-like [GenBank:DQ059082]: No 6. 
Group IV, H. pylori 26695/J99-like: No 28 (see also table 1).
26695 GTTTTCAAGGTCTGGCAAGCCAGACACTCCACTATTTCTAGCGGATTCTCT
J99 -------------A------T------------------------------
I (6) --------------------------------------------------- 26695-type
II (3) -------------A------T------------------------------ J99-type
III (1) ------------------------------------------A-------- “Strain A”-type
IV (1) -------------A------------------------------------- 26695/J99-typeBMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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ureI, sodB, and ureA PCR amplicons of the expected sizes
in all MDA-amplified DNA derived from the H. pylori pos-
itive biopsies and the control strains. However, multiplex
PCR amplification generated only weak bands in No 12
and 22, indicating the presence of a low level of H. pylori
DNA in these biopsies (Fig. 3a). The cagA+/vacA+ combi-
nation was present in six MDA-amplified DNA samples
(No 9, 12, 22, 23, 25, 27) and was also found in the con-
trol strains. The cagA+/vacA- combination was present in
three biopsies (No 6, 14, 18), and the vacA-/cagA- and
vacA+/cagA- combinations were found in one biopsy each
(No 21 and 28, respectively; Fig. 3a).
VacA subtyping by duplex PCR amplification
Multiplex PCR amplification of the 11 H. pylori-positive
MDA-amplified DNA samples yielded seven PCR ampli-
cons with a vacA+ genotype (Fig. 3a). We also used
another  vacA-specific duplex PCR amplification assay
which allows for the discrimination between signal region
s1 and s2 alleles, and midregion m1 and m2 alleles, gen-
erating PCR amplicons of distinct sizes (Table 2). VacA s/
m-profiles were generated from all H. pylori positive MDA-
amplified DNA (Fig. 3b). The vacA  type s1/m1 was
observed in seven MDA-amplified DNA samples (No 9,
12, 22, 23, 25, 27, 28) and the two control strains, and the
vacA type s1/m2 was observed in two biopsies (No 6 and
14). In one case each, only a single band corresponding to
a vacA type s1 (No 18) or a vacA type m2 (No 21) was
found (Fig. 3b; Table 4).
Cytokine SNP and IL1RN-VNTR analysis
MDA-amplified DNA derived from the 28 biopsies was
used for pyrosequencing analysis of the human IL1B-511,
IL1B-31, IL1B+3954 and IFNGR-56 SNPs (Table 5). In the
11 H. pylori-infected biopsy specimens, the SNP CC/CT/
TT-genotype distribution was 4/5/2 for ILB1-511, 3/4/4
for IL1B-31, 8/3/0 for IL1B+3954, and 2/6/3 for IFNGR1-
56. In the 17 H. pylori-negative biopsy specimens, the SNP
CC/CT/TT-genotype distribution was 9/5/3 for IL1B-511,
H. pylori multiplex PCR and vacA subtyping results Figure 3
H. pylori multiplex PCR and vacA subtyping results. Results from the automatic capillary electrophoresis of multiplex 
PCR amplicons derived from 11 H. pylori-infected subjects and control strains H. pylori 26695 and J99. The positions of A)H. 
pylori-specific vacA, hspA, ureI, sodB, ureA, and cagA multiplex PCR amplicons and of B)vacA s1, vacA m1 and vacA m2 PCR ampli-
cons are indicated. Neg represents a non-template control. A virtual internal reference marker is indicated in the left margin.
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Table 4: H. pylori genotyping results.
No 16S rDNA typea MP-PCR vacA-PCRb DNA sequencing analysisc
cagA vacA subtype s-region i-region m-region
6 "Stain A" + - s1/m2 s1a i2 m2
9J 9 9 + + s 1 / m 1 s 1 a i 1 m 1
12 26695 + + s1/m1 s1a i1 m1
14 26695 + - s1/m2 s1a i1-2d m2
18 26695 + - s1/m? s1a i1-2d m2
21 J99 - - s?/m2 s2 i2 m2
22 J99 + + s1/m1 s1b i1 m1
23 26695 + + s1/m1 s1a i1 m1
25 26695 + + s1/m1 s1a i1 m1
27 26695 + + s1/m1 s1a i1 m1
28 26695/J99 - + s1/m1 s1b i1 m1
control HP 26695 + + s1/m1 s1a i1 m1
control HP J99 + + s1/m1 s1b i1 m1
H. pylori virulence-gene typing using MDA-amplified DNA. H. pylori 26695 and J99 were included as control strains.
a) For details see table 1.
b) Question mark indicates the absence of a detectable PCR amplicon (s/m-genotype).
c) The s/i/m-region sequences were aligned and compared with sequences retrieved from GenBank (for details see Materials and methods).
d) The intermediate region represents a mixture of i1/i2 sequences.
Table 5: Cytokine genotyping using MDA-amplified DNA.
Number IL1B-511 (C/T) IL1B-31 (T/C) IL1B +3954 (C/T) IFNGR1-56 (T/C) IL-1RN 86 bp VNTR
6* T/T C/C C/C T/T 1/2
9* C/C T/T C/C T/C 1/1
12* C/C T/T C/T T/T 1/2
14* C/T T/C C/T T/C 1/2
18* C/T T/C C/T T/C 1/2
21* C/T T/C C/C T/C 1/1
22* C/T T/C C/C C/C 1/1
23* C/T C/C C/C T/T 2/2
25* C/C T/T C/C C/C 1/1
27* T/T C/C C/C T/C 1/1
28* C/C T/T C/C T/C 1/1
1 C/T T/C C/C T/C 2/2
2 C/C T/T C/T T/T 1/1
3 C/C T/T C/T T/T 1/1
4 C/C T/T C/C T/T 1/1
5 C/T T/C C/C T/T 1/1
7 C/C T/T C/C T/T 1/1
8 C/T T/C C/C T/T 1/1
10 C/C T/T C/C T/C 1/3
11 T/T C/C C/C T/C 1/2
13 C/T T/C C/T T/C 1/2
15 C/C T/T T/T T/T 1/1
16 T/T C/C C/C T/T 2/2
17 C/C T/T C/C T/C 2/2
19 C/C T/T C/T T/C 1/1
20 C/C T/T C/C C/C 1/2
24 C/T T/C C/C C/C 1/1
26 T/T C/C C/C T/T 1/2
* Indicates H. pylori positive individuals.BMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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3/5/9 for IL1B-31, 12/4/1 for IL1B +3954, and 2/6/9 for
IFNGR1-56 (Table 5).
Capillary electrophoresis revealed an IL1RN-VNTR 1/1-
genotype in six (No 9, 21, 22, 25, 27, 28), a 1/2-genotype
in four (No 6, 12, 14, and 18), and a 2/2-genotype in one
(No 23) of the H. pylori-infected gastritis biopsies. The
biopsy specimen having gastritis without H. pylori infec-
tion (No 8) revealed an IL1RN-VNTR 2/2-genotype. An
IL1RN-VNTR 1/1-genotype was found in eight (No 2, 3, 4,
5, and 7), a 1/2-genotype in four (No 11, 13, 20, 26), a 1/
3-genotype in one (No 10), and a 2/2-genotype in three
(No 1, 16, 17) of the histological normal biopsies (Fig. 4;
Table 5).
VacA subtyping by DNA sequence analysis
DNA sequencing analysis revealed the presence of differ-
ent vacA genotypes in all H. pylori strains, indicating that
sequencing of M13-sequence tagged PCR amplicons is a
more discriminating molecular typing approach than
analysis of PCR amplicons by capillary gel electrophoresis
as done in this study (Fig. 5, 6, 7, 8; Table 4). The apparent
absence of vacA amplicons in the multiplex PCR analysis
of sample no 6, 14, 18 and 21, is explained by a 70 bp
deletion in the RHM region (Fig. 6). The PCR products for
these samples are approximately 600 bp and coincide
with the hsp60 amplicon of similar size (Fig. 3a; Table 2).
DNA sequence alignment revealed ten vacA s1a genotypes
(No 6, 9, 12, 14, 18, 23, 25, 27 and reference strain
26695), three s1b genotypes (No 22, 28, and strain J99)
and one s2 genotype (No 21) when compared to H. pylori
s1a [GenBank:AY185128],  H. pylori s1b [Gen-
Bank:AB057223], and H. pylori s2 [GenBank:AY438687]
as reference sequences (Fig. 5).
Nine H. pylori strains had a vacA type m1 (No 9, 12, 22,
23, 25, 27, 28, and reference strains 26695 and J99) and
four had a type m2 (No 6 14, 18, 21) (Fig. 7; Table 4).
Both i1 and i2 types, but also several chimeric types were
identified. All the m1-type strains revealed an i1 genotype,
No 21 (s2m2) had an i2, and the s1m2-strains (No 6, 14,
and 18) had a chimeric i-region structure (Fig. 8).
DNA sequence analysis of a 900 bp PCR amplicon, pro-
duced using MDA-amplified DNA from biopsy No 18 and
primers M13-seqVac.AS and VAG-R (Fig. 1), revealed a
large deletion in the midregion of the vacA gene resulting
in the absence of several primer target sites (Fig. 6). This
explains the absence of a vacA m1/m2 genotype in the
vacA-subtyping PCR amplification assay of biopsy No 18
(Fig. 3b).
Discussion
Rapidly and easily acquired information on bacterial and
host genes is becoming increasingly important for diagno-
sis and decision-making when choosing suitable therapies
for human infectious diseases. This makes new demands
on clinical research and routine laboratories to develop
molecularly based methods that can accurately identify
and characterise bacterial virulence and host susceptibility
and/or resistance genes. The amount of genomic DNA
available for such genetic analyses is often limited. Quite
often, only minute amounts of bacterial DNA can be
found in human biopsies. Moreover, it is desirable to per-
form concurrent, multiple bacterial and host genotyping
analyses from the same, limited amount of biopsy DNA.
In such studies, the traditional approach is to purify DNA
from cultured bacterial strains isolated from the biopsy
specimens [27]. Sample preparation is commonly carried
out using time-consuming cartridge or bead-based tech-
niques. These methods do not allow an efficient high-
throughput analysis of clinical samples and significant
variations of DNA yield and purity can be observed. By
contrast, an automated nucleic acid extractor combined
with MDA-amplification yields DNA of high purity and
integrity that can be used in downstream applications.
Indeed, recent studies have demonstrated that PCR ampli-
IL1RN-VNTR genotyping results Figure 4
IL1RN-VNTR genotyping results. Automatic capillary electrophoresis of IL1RN-VNTR PCR amplicons from all 28 biopsies. 
The number of each lane corresponds to the sample listed in table 1. The position of the virtual, internal marker and expected 
position of allele *1, *2 and *3 are indicated.
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fications using MDA-amplified DNA can also be carried
out under conditions where PCR amplifications normally
are hampered due to the presence of PCR inhibitors [47].
In recent years, MDA has been tried out for the amplifica-
tion of microbial DNA [36,48,49] and total DNA (bacte-
rial and cellular) isolated from human biopsy specimens
[38,39]. This study shows the feasibility of using MDA-
amplified total DNA, isolated from human biopsy speci-
mens, for research and clinical diagnostic analysis of both
host and infecting bacterium in the same DNA pool.
Pyrosequencing analysis of the16S rDNA variable V3
region revealed the presence of different H. pylori subspe-
cies in the different biopsy specimens which is in agree-
ment with previous reports showing that subtle DNA
sequence variations occur in the 16S rDNA variable V3
region of H. pylori, providing a consistent system for sub-
typing [30,43]. The taxonomy of these H. pylori strains
may be a matter of debate. Subdivision of the species H.
pylori into subspecies, based on biotypes, pathotypes or
serotypes for taxonomic as well as clinical reasons has
been suggested [50,51].
Pro-inflammatory  IL1B  and  IL1RN  polymorphisms are
associated with increased risk of gastric carcinoma in Cau-
casian populations [52]. Carriers of these pro-inflamma-
tory polymorphisms revealed an increased IL1B  gene
expression pattern [19,53] in the mucosa and increased
prevalence of intestinal metaplasia and atrophic gastritis
[19]. Similarly, a genome-wide linkage analysis identified
SNPs in IFNGR1 affecting H. pylori infection [22]. Due to
the limited number of biopsies analysed, we were not able
to draw any statistically significant conclusion regarding
allele frequencies in H. pylori-infected and histologically
normal individuals. However, the primary goal of the
present study was not to perform a clinical study at large
but rather to establish new methodological approaches.
In analogy with these findings we have recently shown
that MDA-DNA derived from minute amounts of archival
plasma/serum DNA allowed us to identify cytokine poly-
morphic SNP-sites by means of pyrosequencing analysis
[40]. The use of IL1B-SNP analysis by means of PCR-
restriction-fragment-length polymorphism where IL1B-
511, IL1B-31 and IL1B+3954 PCR amplicons are digested
with restriction enzyme AvaI, TaqI and AluI, respectively,
is a widely accepted approach [19-21]. However, restric-
tion enzyme digestion, followed by agarose gelelectro-
phoresis is a time consuming and, in a clinical routine
laboratory context, a tedious process requiring up to 100
ng DNA in each assay [20]. Thus, we conclude that MDA-
DNA derived from human biopsy specimens provides a
reliable source for cytokine-SNP analysis and, therefore,
the same approach may be applied for the characterisa-
tion of other host genetic factors in population studies at
large
VacA s-region nucleotide sequence alignment Figure 5
VacA s-region nucleotide sequence alignment. DNA sequence alignment of obtained vacA s-region. The vacA type s1a 
and s1b sequences are shaded in grey. Reference sequences are indicated with NCBI accession number [GenBank:AY185128] 
– s1a, [GenBank:AB057107] – s1c, [GenBank:AB057223] – s1b, and [GenBank:AY438687] – s2. Dots indicate nucleotide 
sequence identical to the one above and gaps indicate deletions. The gaps in the reference sequence are indicated by dashes.BMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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VacA i- and RHM-region nucleotide sequence alignment Figure 6
VacA i- and RHM-region nucleotide sequence alignment. DNA sequence alignment of the obtained sequences contain-
ing intermediate A, B and C, and RHM regions, which are shaded in grey. Reference sequence [GenBank:U05675] (i1) and 
[GenBank:U29401] (i2) are obtained from Rhead et al. [16]. Dots indicate identical nucleotide sequences and gaps indicate 
nucleotide deletions. Primer binding sites are indicated with boxes.BMC Microbiology 2008, 8:175 http://www.biomedcentral.com/1471-2180/8/175
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VacA m-region protein sequence alignment Figure 7
VacA m-region protein sequence alignment. Alignment of deduced amino acid sequence, translated from the obtained 
vacA m-region DNA sequences. Samples with m2 genotype are shaded in grey. Reference sequence [GenBank:U05675] (m1) 
and [GenBank:U29401] (m2) are obtained from Rhead et al. [16]. Dots indicate identical nucleotide sequences and gaps indi-
cate nucleotide deletions.
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VacA i-region protein sequence alignment Figure 8
VacA i-region protein sequence alignment. Amino acid sequence alignment from the vacA variable i-regions. Shaded areas 
indicate the important B and C regions described by Rhead et al. [16].
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Incorporation of universal M13-sequencetags at the 5'-
end of PCR primers facilitated straightforward sequencing
of amplicons, which makes culturing of bacteria from
human biopsy specimens and cloning of PCR amplicons
prior to DNA sequencing unnecessary. This makes it pos-
sible for clinical routine laboratories using this technique
to rapidly produce sequencing results. Sequencing of
M13-tagged amplicons was first described for SPA-typing
[31]. The technique has successfully been applied in our
laboratory for direct sequencing of PCR amplicons in gene
expression studies of vasopressin receptor mRNA splice-
variants expressed in the human gastro-intestinal tract and
surrounding tissues [54]. In the present study we have
used M13 sequence-tags for successful partial sequencing
of the H. pylori virulence vacA gene (Fig. 6). Multiple H.
pylori strain infection was not seen in this study, although
the number of samples included is small. Primer design is
of utter importance since species-specific primers are
essential to gain pure and reliable sequencing results
directly from DNA isolated from a mixed flora.
According to a recent study, the intermediate region (i-
region) of the H. pylori vacA gene is an important and
independent marker of VacA-associated pathogenicity
[16]. All i1-type but no i2-type strains induce vacuolation.
Chimeric versions of the i-region (i1-i2) can induce low
level of vacuolation in vitro. According to this criteria, our
results show two tentatively non-toxic strains (s2/i2/m2-
No 21 and s1/i2/m2- No 6) and one with reduced toxicity
(s1/i1-i2/m2 No 14; No 18 is discussed below). The
remaining biopsies contain toxic H. pylori s1/i1/m1
strains (Table 4).
False negative PCR results from the multiplex-PCR (Table
4) were revealed when using new primers, targeting con-
served regions of the vacA gene. The negative results were
caused by deletions in the RHM region, yielding a smaller
amplicon than expected by previous analysis (Fig. 6). One
sample (No 18) had large deletions in the RHM region of
the gene, leaving out vacA-primer binding sites commonly
used in vacA PCR amplification assays (Fig. 1 and 6). The
sequence contained several premature stop codons down-
stream of the deletion (data not shown), indicating a pos-
sible inactive form of VacA. However, further analysis is
needed in order to establish if this strain can produce an
active protein.
The conclusions to be drawn from the present data is that
the choice of primers in vacA PCR amplification assays
influences the apparent prevalence vacA-positive H. pylori
strains and, hence, precaution has to be taken in the inter-
pretation of vacA-negative PCR amplification results.
Thus, our results are in good agreement with previous
reports that revealed a high level of vacA genotype varia-
tion such as single nucleotide mutations, deletion and in
frame stop codons in the vacA alleles of non-toxic H. pylori
strains [14,15], but it seems questionable to what extent
published  vacA  PCR amplification results can be com-
pared between studies if DNA sequencing is not per-
formed. From our and other studies it seems evident that
it is necessary to establish partial DNA sequences from
either vacA  PCR amplicons (Fig. 3, 5, 6) or from full-
length vacA open reading frames. Thus, high-throughput
sequencing of M13 sequence-tagged PCR amplicons
appears to be a more promising approach, both in
research and clinical routine laboratories. This principle
could be applied to any situation in which sequencing of
PCR amplicons is desirable and thereby, one could
abstain from tedious amplicon cloning and plasmid prep-
aration procedures prior to DNA sequence analysis.
Histology is considered a sensitive method for detection
of H. pylori in gastric biopsies. However, a recent study has
demonstrated that PCR amplification using H. pylori-spe-
cific primers detected H. pylori-DNA in histological-nega-
tive gastric biopsies, indicating the clinical relevance of H.
pylori  detection by PCR amplification in biopsies with
characteristic inflammatory changes [55]. Similarly, Kisa
and co-workers [56] evaluated different diagnostic meth-
ods for the detection of H. pylori in gastric biopsy speci-
mens. In their study the authors concluded that nested
PCR amplification assays are necessary to detect H. pylori-
DNA in gastric biopsy specimens. From this study we con-
clude that MDA-amplified DNA derived from minute
amounts of biopsy specimen DNA is well suited for PCR-
amplification and subsequent sequencing of M13
sequence-tagged amplicons. Thus, it is possible to avoid
nested PCR amplification assays which often have to be
combined with Southern blot analysis to increase the sen-
sitivity and specificity [28,30].
Conclusion
The highly sensitive PCR-based molecular typing methods
described here enables reliable and concurrent genotyp-
ing analyses of bacterial and host cellular DNA from the
same biopsy specimen at a reasonable cost and time.
Although the power of this approach was demonstrated
with concurrent H. pylori and cytokine SNP analysis, the
principles and technologies could be applied to any situ-
ation in which microbial populations are analysed, and in
particular for addressing questions concerning microbial-
host interactions associated with human health in gen-
eral.
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